NASDAQ: PMAXPowell Max Ltd Stock
$0.33+0.01 (+3.13%)
Updated Apr 17, 2025
PMAX Price
$0.33
Fair Value Price
N/A
Market Cap
$4.79M
52 Week Low
$0.28
52 Week High
$4.70
P/E
N/A
P/B
-0.33x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-2.97
Operating Cash Flow
N/A
Beta
1.12
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PMAX's potential to beat the market
- PMAX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diagnostic & Research
Industry Rating
B
PMAX
RankedUnranked of 45
RankedUnranked of 45
Be the first to know about important PMAX news, forecast changes, insider trades & much more!
PMAX News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PMAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PMAX's short-term liabilities ($43.02M) exceed its short-term assets ($24.85M)
Short-term Liabilities Financials
PMAX's short-term assets ($24.85M) exceed its long-term liabilities ($150.00k)
Long-term Liabilities Financials
PMAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more PMAX due diligence checks available for Premium users.
Valuation
PMAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.33x
Industry
3.26x
PMAX's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
Assets to liabilities
Assets
$28.6M
Liabilities
$43.2M
Debt to equity
-2.97
PMAX's short-term liabilities ($43.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PMAX's short-term assets ($24.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PMAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PMAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PMAX vs Diagnostic & Research Stocks
Powell Max Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.